atovaquone has been researched along with Recrudescence in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 12 (46.15) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Cilley, B; Krause, PJ; Nagami, EH; Norris, AM; Rogers, R; Ting, MH; Vannier, E | 1 |
| Castañeda-Mogollón, D; Kamaliddin, C; Kuhn, S; Lang, R; Pillai, DR; Toppings, NB | 1 |
| Chorlton, SD | 1 |
| Camara, L; Queirós, J; Ribeiro, R; Teófilo, E | 1 |
| Chenet, SM; Fernandez, J; Jercic, MI; Lucchi, NW; Oyarce, A; Tapia-Limonchi, R; Tejedo, JR; Udhayakumar, V; Weitzel, T | 1 |
| Hai, F; Islam, S | 1 |
| Akkaya, B; Aydın Teke, T; Bayhan, Gİ; Gayretli Aydın, ZG; Kaman, A; Tanır, G | 1 |
| David, K; Møller, CH | 1 |
| Callens, S; Donck, J; Ommeslag, D; Rogge, S; Van Acker, J; Vantomme, B | 1 |
| Andersen, KG; Bailey, JA; Bazner, S; Freimark, L; Goethert, H; Lemieux, JE; Li, A; McGrath, G; Milner, D; Pritt, B; Rosenberg, E; Sabeti, PC; Schaffner, SF; Sloan, L; Telford, S; Tran, AD; Vannier, E | 1 |
| Burke, M; Chiodini, PL; Fivelman, QL; Klein, JL; Laundy, M; Pasvol, G; Price, N; Sutherland, CJ | 1 |
| Berens-Riha, N; Eshetu, T; Fekadu, S; Gürkov, R; Hölscher, M; Löscher, T; Miranda, IB; Tadesse, Z | 1 |
| Forestier, E; Labe, A; Lecomte, C; Raffenot, D; Rogeaux, O | 1 |
| Freund, KB; Holland, GN; Kreiger, AE; Nguyen, QD; Vance, SK; Wenick, AS | 1 |
| Baron, S; Contentin, L; Desoubeaux, G; Grammatico-Guillon, L; Thanh, HD | 1 |
| Chiodini, P; Evans, M; Morgan, GS | 1 |
| Djossou, F; Etienne, G; Le Bras, M; Longy-Boursier, M; Malvy, D; Pistone, T; Vatan, R | 1 |
| Binh, TQ; De Vries, PJ; Giao, PT; Hung, LQ; Kager, PA; Nam, NV | 1 |
| Björkman, A; Gil, JP; Thapar, MM | 1 |
| Baatz, H; Gümbel, H; Hattenbach, LO; Mirshahi, A; Puchta, J | 1 |
| Lederman, J; Rosenbaum, GS; Tanowitz, HB; Weiss, LM; Wittner, M | 1 |
| Gourdon, D; Katlama, C; Lapierre, D; Mouthon, B; Rousseau, F | 1 |
| Althaus, C; Hudde, T; Schimkat, M; Sundmacher, R | 1 |
| Gray, JS; Pudney, M | 1 |
| Kovacs, JA | 1 |
| Davey, RT; Falloon, J; Feuerstein, I; Hughes, W; Kovacs, J; LaFon, S; Lancaster, D; O'Neill, D; Polis, M; Rogers, M | 1 |
3 trial(s) available for atovaquone and Recrudescence
| Article | Year |
|---|---|
Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiprotozoal Agents; Atovaquone; Clindamycin; Encephalitis; Female; Humans; Male; Naphthoquinones; Pyrimethamine; Recurrence; Risk Factors; Sulfadiazine; Survival Analysis; Time Factors; Toxoplasmosis, Cerebral | 1996 |
Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The NIAID-Clinical Center Intramural AIDS Program.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Anti-Infective Agents; Atovaquone; Biopsy; Enzyme-Linked Immunosorbent Assay; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naphthoquinones; Recurrence; Toxoplasmosis, Cerebral | 1992 |
A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Atovaquone; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Naphthoquinones; Partial Pressure; Pneumonia, Pneumocystis; Recurrence; Treatment Outcome | 1991 |
23 other study(ies) available for atovaquone and Recrudescence
| Article | Year |
|---|---|
Broad Antimicrobial Resistance in a Case of Relapsing Babesiosis Successfully Treated With Tafenoquine.
Topics: Aminoquinolines; Atovaquone; Babesiosis; Drug Resistance; Humans; Recurrence; RNA, Ribosomal, 23S | 2023 |
Amplicon Deep Sequencing Reveals Multiple Genetic Events Lead to Treatment Failure with Atovaquone-Proguanil in Plasmodium falciparum.
Topics: Antimalarials; Atovaquone; Canada; Drug Combinations; High-Throughput Nucleotide Sequencing; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Recurrence; Sepharose; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2023 |
Adjunctive bradyzoite-directed therapy for reducing complications of congenital toxoplasmosis.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Brain; Chorioretinitis; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eye; Humans; Infant; Infant, Newborn; Mice; Models, Biological; Recurrence; Spiramycin; Toxoplasma; Toxoplasmosis, Animal; Toxoplasmosis, Cerebral; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular | 2019 |
Meglumine antimoniate combination treatment for relapsing Kala-azar after treatment and secondary prophylaxis failure with liposomal amphotericin B in two HIV-coinfected patients.
Topics: Adult; Amphotericin B; Atovaquone; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome | 2019 |
Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
Topics: Adult; Antimalarials; Artesunate; Atovaquone; Chile; Cytochromes b; Drug Combinations; Drug Resistance; Female; Gene Expression; Humans; Malaria, Falciparum; Male; Mefloquine; Mutation; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Recurrence; Tetrahydrofolate Dehydrogenase; Travel | 2021 |
Recrudescing Plasmodium malariae infection despite appropriate treatment in an immigrant toddler.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Atovaquone; Chloroquine; Communicable Diseases, Imported; Drug Combinations; Emigrants and Immigrants; Humans; Infant; Liberia; Malaria; Male; Plasmodium malariae; Proguanil; Recurrence; Treatment Outcome; United States | 2018 |
A Case of Recrudescence Plasmodium falciparum Malaria Treated with Atovaquone-Proguanil.
Topics: Adult; Animals; Antimalarials; Atovaquone; Drug Combinations; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Recurrence; Travel; Uganda | 2018 |
Imported malaria is stable from Africa but declining from Asia.
Topics: Adolescent; Adult; Africa; Aged; Antimalarials; Asia; Atovaquone; Chemoprevention; Child; Child, Preschool; Chloroquine; Delayed Diagnosis; Denmark; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Primaquine; Proguanil; Recurrence; Risk Factors; Severity of Illness Index; Travel; Young Adult | 2014 |
Plasmodium falciparum malaria occurring four years after leaving an endemic area.
Topics: Antimalarials; Atovaquone; Disease Transmission, Infectious; Drug Combinations; Endemic Diseases; Female; Ghana; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Proguanil; Recurrence; Travel | 2016 |
A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse.
Topics: Amino Acid Substitution; Animals; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Cytochromes b; Genetic Variation; Genome, Protozoan; High-Throughput Nucleotide Sequencing; Humans; Protein Binding; Recurrence; Ribosomal Proteins; United States; Zoonoses | 2016 |
Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
Topics: Adult; Animals; Antimalarials; Atovaquone; Child, Preschool; Cytochromes b; DNA, Protozoan; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Proguanil; Recurrence; Time Factors; Treatment Failure | 2008 |
Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Atovaquone; Child; Cytochromes b; Drug Combinations; Drug Resistance; Ethanolamines; Ethiopia; Female; Fluorenes; Genotype; Hospitals, University; Humans; Malaria, Falciparum; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Prevalence; Proguanil; Quinine; Recurrence; Sequence Analysis, DNA; Tetrahydrofolate Dehydrogenase; Young Adult | 2010 |
[Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
Topics: Antimalarials; Atovaquone; Cerebrospinal Fluid; Cognition Disorders; Confusion; Diagnosis, Differential; Drug Therapy, Combination; Encephalitis, Herpes Simplex; Hepatitis; Humans; Lymphocyte Count; Malaria, Cerebral; Malaria, Falciparum; Male; Meningitis, Aseptic; Middle Aged; Parasitemia; Proguanil; Recurrence; Syndrome | 2011 |
Diagnostic and therapeutic challenges.
Topics: Adult; Anti-Infective Agents; Atovaquone; Chorioretinitis; Diagnosis, Differential; Eye Diseases; Female; Fluorescein Angiography; Humans; Recurrence; Tomography, Optical Coherence; Toxoplasmosis, Ocular; Visual Acuity; Vitreous Body | 2011 |
[Atovaquone-proguanil treatment failure in Plasmodium falciparum].
Topics: Adult; Antimalarials; Atovaquone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Emigrants and Immigrants; France; Guinea; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Proguanil; Quinine; Recurrence; Travel; Treatment Failure | 2011 |
Relapsing malaria: two cases of malaria presenting 8 months after return from Africa despite adherence to antimalarial chemoprophylaxis.
Topics: Adolescent; Africa; Antimalarials; Atovaquone; Delayed Diagnosis; Drug Combinations; Humans; Malaria; Male; Medication Adherence; Plasmodium ovale; Proguanil; Recurrence; Travel; United Kingdom | 2012 |
[Experience with the combination atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria--report of 112 cases].
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Drug Therapy, Combination; Female; Gastritis; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Proguanil; Recurrence; Retrospective Studies; Treatment Outcome | 2002 |
Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Recurrence; Sesquiterpenes; Treatment Failure; Vietnam | 2003 |
In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.
Topics: Animals; Antimalarials; Atovaquone; Culture Media; Cytochrome b Group; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Naphthoquinones; Parasitic Sensitivity Tests; Plasmodium falciparum; Proguanil; Recurrence; Triazines | 2005 |
Reactivation of toxoplasma retinochoroiditis under atovaquone therapy in an immunocompetent patient.
Topics: Adult; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Drug Resistance, Microbial; Female; Humans; Immunocompetence; Naphthoquinones; Oxidoreductases; Recurrence; Toxoplasma; Toxoplasmosis, Ocular; Visual Acuity | 2006 |
Atovaquone in the treatment of Babesia microti infections in hamsters.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Antiprotozoal Agents; Artemisinins; Atovaquone; Azithromycin; Babesiosis; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Naphthoquinones; Parasitemia; Recurrence; Sesquiterpenes | 1996 |
[Treatment of toxoplasmosis retinochoroiditis with atovaquone in an immunocompetent patient].
Topics: Adult; Animals; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Female; Follow-Up Studies; Humans; Male; Naphthoquinones; Recurrence; Toxoplasma; Toxoplasmosis, Ocular | 1996 |
Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus.
Topics: Acute Disease; Animals; Antiprotozoal Agents; Atovaquone; Babesiosis; Chronic Disease; Clindamycin; Diminazene; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Gerbillinae; Humans; Imidocarb; Naphthoquinones; Pentamidine; Recurrence | 1999 |